Essential cookies by default. The browser ID, load-time metrics and error replays only run if you choose "Accept all".
Head-to-head evidence comparison — which supplement is right for you?
Clascoterone vs Clindamycin (topical): Clascoterone has the stronger overall evidence (7 vs 6.5/10); they're alternatives for clearer skin (acne) — the best pick depends on your goals. Take the 2-minute quiz for a pick tailored to your goals.
Clascoterone wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
Top outcomes
Verdict
Too few graded studies
Top outcomes
Shared outcomes (1)
Outcomes where both Clascoterone and Clindamycin (topical) have evidence — compare verdict strength side-by-side.
A source-matched dose range is not available for this product and use.
If this treatment was prescribed for you, follow your prescriber’s directions. Do not change prescribed treatment because this page has no matched dose range.
Morning and evening
Clascoterone 1% cream
A source-matched dose range is not available for this product and use.
If this treatment was prescribed for you, follow your prescriber’s directions. Do not change prescribed treatment because this page has no matched dose range.
Morning
Fixed-dose clindamycin 1% with benzoyl peroxide
immediate
12 weeks
12 weeks
1-4 weeks
long-term
long-term
long-term
long-term
Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials
JAMA Dermatol (2020) · RCT · n=1440
The pivotal registration trials: two identical phase 3 studies, 1440 patients randomised, conducted November 2015 to April 2018.
Efficacy and Safety of 1% Clascoterone Cream in Patients Aged > 12 Years With Acne Vulgaris
J Drugs Dermatol (2023) · RCT · n=1421
709 patients received clascoterone and 712 received vehicle in the pooled ≥12-year population.
Efficacy and safety of topical clascoterone cream for treatment of acne vulgaris: A systematic review and meta-analysis of randomized placebo-controlled trials
Dermatol Ther (2021) · Meta-Analysis · n=2457
Five trials, 2457 patients (1357 clascoterone, 1100 placebo), overall low risk of bias.
Topical antibiotic monotherapy only provides mild benefit for patients with acne vulgaris: a systematic review and network meta-analysis
Clin Drug Investig (2026) · Meta-Analysis · n=22645
32 studies comprising 34 randomised controlled trials, 22,645 patients, searched to October 2025.
Efficacy of topical treatments for mild-to-moderate acne: a systematic review and meta-analysis of randomized controlled trials
J Eur Acad Dermatol Venereol (2025) · Meta-Analysis · n=33472
35 randomised clinical trials, 33,472 participants, nine topical agents, minimum 12 weeks of treatment.
Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne
J Am Acad Dermatol (2010) · Meta-Analysis · n=7309
23 studies, 7,309 patients, conducted under Cochrane guidance and reported to PRISMA.
Clascoterone has a higher evidence score (7/10 vs 6.5/10) and wins in 2 of 3 categories.
For clearer skin (acne), Clascoterone has a higher relevance score (92 vs 62).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.